Influenza treatment and prophylaxis with neuraminidase inhibitors: a review by Kamali A, Holodniy M

Get full text

Connection domain mutations in treatment-experienced patients in the OPTIMA trial. by Dau, B, Ayers, D, Singer, J, Harrigan, P, Brown, S, Kyriakides, T, Cameron, D, Angus, B, Holodniy, M

The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals... by Brown, S, Tate, J, Kyriakides, T, Kirkwood, K, Holodniy, M, Goulet, J, Angus, B, Cameron, D, Justice, A

Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease. by Bayoumi, A, Barnett, P, Joyce, V, Griffin, S, Sun, H, Bansback, N, Holodniy, M, Sanders, G, Brown, S, Kyriakides, T, Angus, B, Cameron, D, Anis, A, Sculpher, M, Owens, D

Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial. by Holodniy, M, Brown, S, Cameron, D, Kyriakides, T, Angus, B, Babiker, A, Singer, J, Owens, D, Anis, A, Goodall, R, Hudson, F, Piaseczny, M, Russo, J, Schechter, M, Deyton, L, Darbyshire, J